Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Equity Ratio (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Equity Ratio for 16 consecutive years, with 0.96 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio changed 0.36% to 0.96 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.96, a 0.36% change, with the full-year FY2024 number at 0.95, down 1.5% from a year prior.
  • Equity Ratio was 0.96 for Q3 2025 at Creative Medical Technology Holdings, down from 0.96 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.98 in Q2 2022 to a low of 2.8 in Q1 2021.
  • A 5-year average of 0.6 and a median of 0.96 in 2024 define the central range for Equity Ratio.
  • Biggest YoY gain for Equity Ratio was 946.74% in 2022; the steepest drop was 8.81% in 2022.
  • Creative Medical Technology Holdings' Equity Ratio stood at 0.91 in 2021, then fell by 8.81% to 0.83 in 2022, then increased by 16.75% to 0.97 in 2023, then decreased by 1.5% to 0.95 in 2024, then rose by 0.47% to 0.96 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Equity Ratio are 0.96 (Q3 2025), 0.96 (Q2 2025), and 0.97 (Q1 2025).